Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers.

Détails

Ressource 1Demande d'une copie Sous embargo indéterminé.
Etat: Public
Version: de l'auteur
ID Serval
serval:BIB_DE23A122EB32
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers.
Périodique
Pharmacogenetics and Genomics
Auteur(s)
Dobrinas M., Cornuz J., Eap C.B.
ISSN
1744-6880 (Electronic)
ISSN-L
1744-6872
Statut éditorial
Publié
Date de publication
2013
Peer-reviewed
Oui
Volume
23
Numéro
5
Pages
286-292
Langue
anglais
Notes
Publication types: Journal ArticlePublication Status: ppublish
Résumé
BACKGROUND: There is a high interindividual variability in cytochrome P4501A2 (CYP1A2) activity and in its inducibility by smoking, only poorly explained by known CYP1A2 polymorphisms. We aimed to study the contribution of other regulatory pathways, including transcription factors and nuclear receptors, toward this variability.
METHODS: CYP1A2 activity was determined by the paraxanthine/caffeine ratio in 184 smokers and in 113 of them who were abstinent for 4 weeks. Participants were genotyped for 22 polymorphisms in 12 genes.
RESULTS: A significant influence on CYP1A2 inducibility was observed for the NR1I3 rs2502815 (P=0.0026), rs4073054 (P=0.029), NR2B1 rs3818740 (P=0.0045), rs3132297 (P=0.036), AhR rs2282885 (P=0.040), rs2066853 (P=0.019), NR1I1 rs2228570 (P=0.037), and NR1I2 rs1523130 (P=0.044) polymorphisms. Among these, the NR1I3 rs2502815 (P=0.0045), rs4073054 (P=0.048), and NR2B1 rs3818740 (P=0.031) also influenced CYP1A2 basal activity.
CONCLUSION: This is the first in-vivo demonstration of the influence of genes involved in CYP1A2 regulatory pathways on its basal activity and inducibility by smoking. These results need to be confirmed by other studies.
Pubmed
Web of science
Création de la notice
04/04/2013 14:58
Dernière modification de la notice
20/08/2019 16:02
Données d'usage